Tag: nhs

Vital Hydrocortisone tablets at the centre of suspected excessive and unfair pricing to the NHS

First published by Admin on March 09, 2018 in the following categories: Price Hikes and tagged with nhs | overpriced medication

The Competition and Markets Authority (CMA) are investigating price-hikes of vital hydrocortisone tablets on the basis that they suspect they are being excessively inflated.

Intas Pharmaceuticals Limited and Accord Healthcare Limited, which acquired Actavis UK in January 2017, are at the centre of the CMA’s investigations. The suspicion is breaches of competition laws through unfair prices over the supply of hydrocortisone tablets in the UK to the NHS.
read more